Pharmstandard put $1 million into the company Genotek, which is engaged in DNA research. Among the shareholders of the company are the former head of the presidential administration Alexander Voloshin, co-owner of the agricultural holding Rusagro Maxim Basov and a partner of Safmar Ventures.